Johnson & Johnson has launched its "Dual control" campaign in Asia Pacific, aiming to empower patients with inflammatory bowel disease (IBD) to manage their condition while pursuing life goals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback